drugset / Trial / NCT04064073
Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study)
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate drug-drug interaction of DWP16001 in combination with metformin IR 1000mg in Healthy male subjects.
Timeline
- Start
- 2019-08-14
- Primary completion
- 2019-11-20
- Completion
- 2019-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enavogliflozin | Small molecule | — | Oral |
| Subject | Metformin | Small molecule | 1000 mg | Oral |
Indications
No indication recorded.